Does GILTERITINIB Cause Haemoglobin decreased? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Haemoglobin decreased have been filed in association with GILTERITINIB (Xospata). This represents 1.6% of all adverse event reports for GILTERITINIB.
57
Reports of Haemoglobin decreased with GILTERITINIB
1.6%
of all GILTERITINIB reports
7
Deaths
23
Hospitalizations
How Dangerous Is Haemoglobin decreased From GILTERITINIB?
Of the 57 reports, 7 (12.3%) resulted in death, 23 (40.4%) required hospitalization, and 2 (3.5%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GILTERITINIB. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does GILTERITINIB Cause?
Acute myeloid leukaemia (366)
Febrile neutropenia (346)
Off label use (334)
Platelet count decreased (327)
Pneumonia (302)
Myelosuppression (300)
Pyrexia (281)
Death (206)
Product use issue (189)
Hepatic function abnormal (181)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which GILTERITINIB Alternatives Have Lower Haemoglobin decreased Risk?
GILTERITINIB vs GIMERACIL\OTERACIL\TEGAFUR
GILTERITINIB vs GINKGO
GILTERITINIB vs GIVINOSTAT
GILTERITINIB vs GIVOSIRAN
GILTERITINIB vs GLASDEGIB